Market Highlights

According to CRI analysis, the global low-pressure liquid chromatography market is expected to register a CAGR of ~3.6% from 2020 to 2027.

The global low-pressure liquid chromatography market is driven by the expansion of research facilities across the globe, increasing government funding in the healthcare sector, and the rising population diagnosed with hereditary disorders such as Parkinson’s disease, sickle cell disease, and Alzheimer’s disease.

In addition, increasing demand for DNA-based, RNA-based, and protein-based medicines to treat hereditary problems has created opportunities for the market players. Additionally, the low-pressure liquid chromatography systems segregate proteins, nucleic acids, and other small & complex molecules involved in several biological procedures.

Moreover, the low-pressure liquid chromatography is also utilized to separate two polar organic solutes, screen drugs in sports, and segregate a wide range of hypersensitive and nonsteroidal anti-inflammatory drugs. The rise in the adoption of such biological extraction methodologies is expected to augment the low-pressure liquid chromatography market.

The industry providers are involved in technological enhancement, product development, expansion of distribution network, investment public relations, and mergers & acquisitions to expand their global footprint. The industry players are planning to adopt business plans such as the development of advanced low-pressure liquid chromatography systems to provide accurate and efficient test and extraction results.

Additionally, the global market players aim to invest in the developing countries owing to supportive government policies, economic labor costs, and the high availability of raw materials. These factors will strengthen the market development and will propel the market demand in the projected period.  

Regional Analysis

North America is projected to dominate the low-pressure liquid chromatography market in the forecast period, owing to the presence of a large number of market players, increasing government fundings, expansion in research facilities, extensive distribution network, and growing usage of chromatography in drug development.

Furthermore, the key players are involved in business approaches such as collaborations, mergers, technical partnerships, government alliances, and an increasing number of clinical trials are a few of the factors propelling the market growth.

Europe embraces the second-largest position in the low-pressure liquid chromatography market due to the increasing development, manufacturing, and commercialization of therapeutics, increasing establishment of analytical and biotechnology laboratories across the region.

Likewise, increasing the utilization of molecular diagnosis for forensic investigation is driving the European low-pressure liquid chromatography market. The industry players provide high-quality products and superior after-sales service to gain an edge over the existing industry providers. These business parameters are expected to propel the low-pressure liquid chromatography market in the anticipated time.

Asia-Pacific is likely to hold the major market share over the assessed timeline due to the transformation in pharmaceutical infrastructure, high investment in the modernization of research laboratories, rising demand for generic and advanced medicines across the region, and increasing awareness about genetic and molecular drugs.

Moreover, the rising demand for environmental and chemical analysis devices and equipment is driving the Asia-Pacific low-pressure liquid chromatography market.

Furthermore, the development of the market in the Rest of the World has been gaining market share in the low-pressure liquid chromatography market over the last few years due to the growing interest of investors in the local research facilities, supportive government regulations, establishment of technically advanced pharmaceutical infrastructure and growing research activities on the extraction of molecular components such as proteins, RNA, DNA, and other complex molecules. These aspects are likely to fuel the market growth over the assessed period.

Segmentation

The global low-pressure liquid chromatography market is segmented into components and end user. Based on component, the market has been segregated into instruments, consumables, and services. The instruments segment held a considerable market share in 2020.

The demand for low-pressure liquid chromatography is the largest contributor to the global market due to its high engagement in research facilities to derive COVID-19 vaccines and other microbial infection treatments. In addition, the ongoing innovation of drugs and treatment for chronic diseases are strengthening the demand for low-pressure liquid chromatography products.

Based on end user, the global low-pressure liquid chromatography market has been classified as pharmaceutical companies, biotechnology companies, research laboratories, and academic institutions. Pharmaceutical companies held a considerable share of the market in 2020, owing to the high demand for medicines across the globe due to the spread of deadly coronavirus and chronic diseases.

Additionally, increasing public and private investments in drug development and growing funding in the pharmaceutical sector to transform the research and production facilities are expected to drive the segment in the projected timeline.

Key Players

Some of the key players in the global low-pressure liquid chromatography market are Novasep (France), LEWA GmbH (Germany), GALAK Chromatography Technology Co., Ltd (China), Biolinx Labsystems (India), and Bio-Rad Laboratories, Inc. (US).

The post global low-pressure liquid chromatography market 2027 first appeared on CRI Report.